MRNA Competitors & Alternatives
Compare Moderna Inc with similar stocks in the same industry
Biotechnology
MRNA
Main Stock$60.57
Tradestie Score
55
Market Cap
$10.74B
Revenue Growth
0.0%
Analyst Upside
-16.1%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$132.57
|
$31.13B | - | 27 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$92.80
|
$24.57B | - | 51 | Compare |
|
ZM
Zoom Communications, Inc. Class A Common Stock
|
$106.06
|
$24.33B | 15.8 | 28 | Compare |
|
GMAB
Genmab A/S ADS
|
$30.85
|
$19.56B | 24.7 | 46 | Compare |
|
NIO
NIO Inc. American depositary shares, each representing one Class A ordinary share
|
$4.62
|
$18.85B | - | 65 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.07
|
$16.93B | 15.5 | 49 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.79
|
$15.70B | 30.5 | 56 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.12
|
$15.22B | - | 48 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$254.57
|
$12.36B | 29.2 | 63 | Compare |
|
EXEL
Exelixis Inc
|
$51.33
|
$11.09B | 16.7 | 41 | Compare |
More MRNA Analysis
Data updated: Aug 12, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry